USNA - USANA Health Sciences Inc Stock Price, Fair Value and News

42.20USD-0.78 (-1.81%)Delayed as of 30 Apr 2024, 12:51 pm ET

Market Summary

USD42.20-0.78

Delayedas of 30 Apr 2024, 12:51 pm

-1.81%

USNA Stock Price

View Fullscreen

USNA RSI Chart

USNA Valuation

Market Cap

827.0M

Price/Earnings (Trailing)

12.96

Price/Sales (Trailing)

0.9

EV/EBITDA

4.3

Price/Free Cashflow

14.73

USNA Price/Sales (Trailing)

USNA Profitability

EBT Margin

11.12%

Return on Equity

12.83%

Return on Assets

10.08%

Free Cashflow Yield

6.79%

USNA Fundamentals

USNA Revenue

Revenue (TTM)

921.0M

Rev. Growth (Yr)

-3.02%

Rev. Growth (Qtr)

3.62%

USNA Earnings

Earnings (TTM)

63.8M

Earnings Growth (Yr)

31.04%

Earnings Growth (Qtr)

47.76%

Breaking Down USNA Revenue

52 Week Range

42.2069.60

(Low)(High)

Last 7 days

-2.8%

Last 30 days

-11.4%

Last 90 days

-9.9%

Trailing 12 Months

-35.2%

How does USNA drawdown profile look like?

USNA Financial Health

Current Ratio

3.52

USNA Investor Care

Buy Backs (1Y)

0.28%

Diluted EPS (TTM)

3.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	974.1M	947.8M	927.9M	921.0M
2022	1.2B	1.1B	1.0B	998.6M
2021	1.2B	1.3B	1.2B	1.2B
2020	1.1B	1.1B	1.1B	1.1B
2019	1.2B	1.1B	1.1B	1.1B
2018	1.1B	1.1B	1.2B	1.2B
2017	1.0B	1.0B	1.0B	1.0B
2016	939.6M	964.8M	985.8M	1.0B
2015	827.4M	872.4M	913.8M	918.5M
2014	731.5M	730.6M	748.9M	790.5M
2013	663.7M	691.9M	700.4M	718.2M
2012	592.5M	604.5M	626.1M	648.7M
2011	542.1M	565.0M	573.5M	581.9M
2010	0	463.8M	490.7M	517.6M
2009	0	0	0	436.9M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of USANA Health Sciences Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 24, 2024	fleming john turman	acquired	-	-	490	-
Apr 24, 2024	winssinger frederic j	acquired	-	-	490	-
Apr 24, 2024	pelosi peggie	acquired	-	-	490	-
Apr 24, 2024	pelosi peggie	sold (taxes)	-12,279	43.7	-281	-
Apr 24, 2024	ding xia	sold (taxes)	-5,375	43.7	-123	-
Apr 24, 2024	nixon j scott	acquired	-	-	490	-
Apr 24, 2024	wood timothy e	acquired	-	-	490	-
Apr 24, 2024	fuller gilbert a	acquired	-	-	490	-
Apr 24, 2024	ding xia	acquired	-	-	490	-
Mar 11, 2024	guest kevin	sold	-539,539	49.00	-11,011	exec. chairman of the board

Which funds bought or sold USNA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 26, 2024	YOUSIF CAPITAL MANAGEMENT, LLC	reduced	-8.55	-50,845	243,955	-%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	unchanged	-	-12,795	121,687	-%
Apr 25, 2024	Lindbrook Capital, LLC	reduced	-22.98	-5,231	12,028	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	new	-	12,000	12,000	-%
Apr 25, 2024	NEW YORK STATE TEACHERS RETIREMENT SYSTEM	reduced	-5.19	-103,000	620,000	-%
Apr 25, 2024	nVerses Capital, LLC	new	-	111,550	111,550	0.27%
Apr 25, 2024	Allworth Financial LP	reduced	-50.00	-176	146	-%
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-11.17	-1,091,080	4,470,250	-%
Apr 24, 2024	Assenagon Asset Management S.A.	added	58.95	1,214,780	3,986,650	0.01%
Apr 24, 2024	Robeco Institutional Asset Management B.V.	reduced	-0.26	-124,482	1,152,220	-%

Are Funds Buying or Selling USNA?

Are funds buying USNA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own USNA

No. of Funds

Unveiling USANA Health Sciences Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	renaissance technologies llc	6.27%	1,198,697	SC 13G/A
Feb 13, 2024	vanguard group inc	8.27%	1,582,742	SC 13G/A
Jan 24, 2024	blackrock inc.	9.6%	1,836,679	SC 13G/A
Feb 13, 2023	renaissance technologies llc	6.38%	1,224,997	SC 13G/A
Feb 09, 2023	vanguard group inc	7.99%	1,534,910	SC 13G/A
Jan 06, 2023	blackrock inc.	10.2%	1,963,866	SC 13G/A
Feb 11, 2022	renaissance technologies llc	7.48%	1,456,097	SC 13G/A
Feb 10, 2022	vanguard group inc	7.70%	1,498,731	SC 13G/A
Feb 01, 2022	blackrock inc.	9.3%	1,802,996	SC 13G/A
Nov 22, 2021	wentz myron w	41.0%	7,985,743	SC 13D/A

Recent SEC filings of USANA Health Sciences Inc

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Apr 25, 2024	4	Insider Trading
Mar 27, 2024	DEFA14A	DEFA14A
Mar 27, 2024	ARS	ARS
Mar 22, 2024	DEF 14A	DEF 14A

Peers (Alternatives to USANA Health Sciences Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADM	30.9B	93.9B	-3.38%	-22.27%	8.88	0.33	-7.50%	-19.75%
BG	15.0B	61.3B	0.94%	10.56%	7.7	0.25	-8.91%	30.43%
CAG	14.8B	12.1B	4.39%	-18.49%	15.54	1.22	-0.78%	18.26%
CPB	13.4B	9.3B	1.08%	-17.26%	17.49	1.44	1.02%	-5.78%
ACI	11.6B	79.2B	-4.99%	-2.54%	8.97	0.15	2.05%	-14.37%
MID-CAP
BRBR	7.4B	1.7B	-4.86%	56.04%	44.53	4.24	21.49%	39.64%
FLO	5.2B	5.1B	4.59%	-9.71%	42.4	1.03	5.93%	-45.96%
FRPT	5.2B	766.9M	-7.00%	56.23%	-154.8	6.79	28.82%	43.50%
CALM	2.8B	2.4B	-2.02%	21.39%	10.19	1.18	-22.17%	-63.60%
CENT	2.8B	3.3B	-3.71%	42.95%	20.49	0.83	0.37%	-0.15%
SMALL-CAP
ANDE	1.9B	14.8B	-0.17%	28.12%	19.15	0.13	-14.86%	-22.80%
BGS	883.7M	2.1B	-1.75%	-27.55%	-13.35	0.43	-4.65%	-482.22%
BYND	434.6M	343.4M	-18.84%	-50.37%	-1.29	1.27	-18.04%	7.65%
ALCO	217.6M	106.3M	-2.49%	21.18%	4.54	2.05	34.67%	5930.90%
AQB	7.5M	2.5M	-3.96%	259.26%	-0.27	3.03	-21.18%	-24.37%

USANA Health Sciences Inc News

Latest updates

USANA Health Sciences Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	3.6%	221	213	238	248	228	233	264	273	267	274	337	308	311	299	259	267	271	261	256	273	299
Gross Profit	4.6%	179	171	195	200	182	187	215	221	215	224	280	250	252	242	211	221	224	213	210	227	250
Operating Expenses	0.9%	155	153	170	173	159	164	186	188	183	183	226	206	199	197	172	182	179	177	178	192	201
S&GA Expenses	-7.3%	59.00	63.00	68.00	67.00	61.00	66.00	66.00	69.00	69.00	67.00	72.00	72.00	69.00	66.00	61.00	65.00	65.00	66.00	67.00	70.00	68.00
EBITDA Margin	3.9%	0.13*	0.12*	0.12*	0.12*	0.12*	0.13*	0.14*	0.15*	0.15*	0.17*	0.17*	0.17*	-	-	-	-	-	-	-	-	-
Interest Expenses	237.2%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.11	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Taxes	7.2%	10.00	9.00	10.00	10.00	10.00	8.00	10.00	11.00	11.00	13.00	16.00	14.00	15.00	14.00	12.00	13.00	15.00	12.00	11.00	12.00	17.00
Earnings Before Taxes	29.6%	27.00	21.00	27.00	29.00	23.00	23.00	29.00	33.00	32.00	40.00	54.00	44.00	55.00	44.00	40.00	39.00	46.00	36.00	33.00	36.00	49.00
EBT Margin	4.6%	0.11*	0.11*	0.11*	0.11*	0.11*	0.11*	0.12*	0.14*	0.14*	0.16*	0.16*	0.16*	-	-	-	-	-	-	-	-	-
Net Income	47.8%	17.00	11.00	17.00	18.00	13.00	15.00	19.00	22.00	20.00	27.00	38.00	31.00	40.00	31.00	28.00	27.00	31.00	24.00	21.00	24.00	32.00
Net Income Margin	7.4%	0.07*	0.06*	0.07*	0.07*	0.07*	0.07*	0.08*	0.09*	0.10*	0.11*	0.11*	0.11*	-	-	-	-	-	-	-	-	-
Free Cashflow	-10.0%	19.00	21.00	6.00	11.00	37.00	26.00	13.00	18.00	22.00	31.00	38.00	18.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	5.3%	633	601	603	606	597	556	558	573	578	579	591	585	641	578	512	474	517	463	532	552	554
Current Assets	7.0%	418	390	388	396	384	341	342	364	365	368	382	373	425	386	325	287	329	283	349	370	392
Cash Equivalents	7.6%	330	307	300	295	288	247	230	238	240	249	265	257	312	278	227	194	235	183	231	225	214
Inventory	2.3%	61.00	60.00	62.00	64.00	67.00	67.00	84.00	98.00	98.00	96.00	90.00	88.00	90.00	78.00	69.00	61.00	69.00	76.00	88.00	86.00	82.00
Net PPE	4.9%	100	95.00	96.00	97.00	98.00	95.00	98.00	101	102	101	98.00	99.00	100	99.00	98.00	97.00	95.00	92.00	93.00	92.00	92.00
Goodwill	1.8%	17.00	17.00	17.00	17.00	17.00	17.00	1.00	18.00	18.00	18.00	17.00	17.00	17.00	17.00	17.00	16.00	17.00	16.00	17.00	17.00	17.00
Current Liabilities	5.6%	119	113	114	130	144	126	134	158	161	158	153	151	168	161	140	125	136	130	129	130	149
Shareholder's Equity	5.7%	497	470	469	455	434	411	404	390	395	399	419	403	442	389	349	318	352	314	384	391	391
Retained Earnings	3.9%	445	428	427	410	392	379	364	345	345	350	366	353	383	343	313	285	306	275	328	329	330
Additional Paid-In Capital	5.6%	66.00	62.00	60.00	56.00	56.00	52.00	49.00	46.00	50.00	51.00	54.00	54.00	62.00	59.00	56.00	52.00	59.00	57.00	69.00	69.00	72.00
Shares Outstanding	0.0%	19.00	19.00	19.00	19.00	19.00	19.00	19.00	19.00	20.00	20.00	21.00	21.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	699	-	-	-	1,426	-	-	-	2,052	-	-	-	817	-	-	-	1,040	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	17.0%	26,023	22,234	9,551	12,833	40,463	29,125	14,613	19,701	24,922	37,488	39,158	19,659	47,915	49,062	32,638	30,786	55,740	50,314	15,158	5,521	40,426
Share Based Compensation	-0.7%	3,643	3,670	3,674	3,608	3,516	3,076	3,556	3,183	3,259	3,454	3,845	3,740	3,875	3,528	3,597	3,394	2,857	4,083	4,769	3,832	3,929
Cashflow From Investing	-403.6%	-7,322	-1,454	179	-3,378	-3,282	-3,579	-3,723	-1,786	-3,153	-6,452	-1,494	-3,088	-21,433	-2,732	-1,526	-8,270	-5,105	-1,185	21,275	32,509	15,611
Cashflow From Financing	105.7%	658	-11,641	-55.00	-3,199	-150	-44.00	-10,301	-19,593	-32,445	-46,831	-31,661	-70,475	-472	-43.00	-75.00	-58,852	-305	-92,476	-27,858	-31,413	-80,218
Buy Backs	-100.0%	-	11,657	-	-	-	-	-	25,382	31,343	49,751	29,701	67,610	-	-	-	57,029	-	92,377	27,623	30,000	79,785

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

USNA Income Statement

2023-12-30

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Statement [Abstract]
Net sales	$ 921,010	$ 998,601	$ 1,186,464
Cost of sales	176,693	193,890	217,898
Gross profit	744,317	804,711	968,566
Operating expenses:
Associate incentives	394,257	434,793	519,267
Selling, general and administrative	256,989	262,304	279,107
Total operating expenses	651,246	697,097	798,374
Earnings from operations	93,071	107,614	170,192
Other income (expense):
Interest income	9,637	3,789	2,515
Interest expense	(262)	(192)	(57)
Other, net	7	(2,590)	(2,008)
Other income (expense), net	9,382	1,007	450
Earnings before income taxes	102,453	108,621	170,642
Income taxes	38,665	39,271	54,137
Net earnings	$ 63,788	$ 69,350	$ 116,505
Earnings per common share
Earnings per share, basic (in dollars per share)	$ 3.31	$ 3.60	$ 5.78
Earnings per share, diluted (in dollars per share)	$ 3.30	$ 3.59	$ 5.73
Weighted average common shares outstanding
Basic (in shares)	19,250	19,254	20,146
Diluted (in shares)	19,345	19,310	20,343
Comprehensive income:
Net earnings	$ 63,788	$ 69,350	$ 116,505
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(1,298)	(15,126)	2,203
Tax benefit (expense) related to foreign currency translation adjustment	390	1,881	1,880
Other comprehensive income (loss), net of tax	(908)	(13,245)	4,083
Comprehensive income	$ 62,880	$ 56,105	$ 120,588

USNA Balance Sheet

2023-12-30

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 330,420	$ 288,420
Inventories	61,454	67,089
Prepaid expenses and other current assets	25,872	28,873
Total current assets	417,746	384,382
Property and equipment, net	99,814	97,773
Goodwill	17,102	17,368
Intangible assets, net	29,919	32,432
Deferred tax assets	13,284	9,799
Other assets	54,892	54,795
Total assets	632,757	596,549
Current liabilities
Accounts payable	10,070	11,049
Line of credit - short term	786	0
Other current liabilities	107,989	132,784
Total current liabilities	118,845	143,833
Deferred tax liabilities	4,552	4,071
Other long-term liabilities	12,158	14,173
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 2022	19	19
Additional paid-in capital	65,661	55,604
Retained earnings	445,217	391,636
Accumulated other comprehensive income (loss)	(13,695)	(12,787)
Total stockholders' equity	497,202	434,472
Total liabilities and equity	$ 632,757	$ 596,549

About USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

CEO	Mr. Jim Brown
WEBSITE	usana.com
INDUSTRY	Packaged Foods
EMPLOYEES	1900

USANA Health Sciences Inc Frequently Asked Questions

What is the ticker symbol for USANA Health Sciences Inc? What does USNA stand for in stocks?

USNA is the stock ticker symbol of USANA Health Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of USANA Health Sciences Inc (USNA)?

As of Mon Apr 29 2024, market cap of USANA Health Sciences Inc is 826.96 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of USNA stock?

You can check USNA's fair value in chart for subscribers.

What is the fair value of USNA stock?

You can check USNA's fair value in chart for subscribers. The fair value of USANA Health Sciences Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of USANA Health Sciences Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for USNA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is USANA Health Sciences Inc a good stock to buy?

The fair value guage provides a quick view whether USNA is over valued or under valued. Whether USANA Health Sciences Inc is cheap or expensive depends on the assumptions which impact USANA Health Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for USNA.

What is USANA Health Sciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 29 2024, USNA's PE ratio (Price to Earnings) is 12.96 and Price to Sales (PS) ratio is 0.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. USNA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on USANA Health Sciences Inc's stock?

In the past 10 years, USANA Health Sciences Inc has provided 0.094 (multiply by 100 for percentage) rate of return.